Back to search

Article

Seroprevalence of Antibodies to SARS-CoV-2 in US Blood Donors

2020-09-18

Abstract excerpt

<h4>Background</h4> To identify blood donors eligible to donate Coronavirus Disease-2019 (COVID-19) Convalescent Plasma (CCP), a large blood center began testing for antibodies to SARS-CoV-2, the etiologic agent of COVID-19. We report the seroprevalence of total immunoglobulin directed against the S1 spike protein of SARS-CoV-2 in US blood donors. <h4>Methods</h4> Unique non-CCP donor sera from June 1–July 31, 202...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
14836bbc-f5d9-5e0f-8232-807188cb571a
DOI
10.1101/2020.09.17.20195131
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Seroprevalence of Antibodies to SARS-CoV-2 in US Blood DonorsDOI 10.1101/2020.09.17.20195131
Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance ProgramSemantic proximity
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa during the period January-May 2021Semantic proximity
Vaccination of COVID-19 Convalescent Plasma Donors Increases Binding and Neutralizing Antibodies Against SARS-CoV-2 VariantsSemantic proximity
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping reviewSemantic proximity
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor populationSemantic proximity
High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samplesSemantic proximity
SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitalsSemantic proximity
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021.Semantic proximity
Dynamics of SARS-CoV-2-specific antibodies during and after COVID19: Lessons from a biobank in ArgentinaSemantic proximity
High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samplesSemantic proximity
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)Semantic proximity
A serological assay to detect SARS-CoV-2 seroconversion in humansSemantic proximity
Select a neighboring publication to make it the new centre.